MedPath

Cumulative effects of transcranial direct current stimulation on meth craving

Phase 2
Conditions
Methamphetamine dependency.
Dependence syndrom, Mental and behavioural disorders due to use of other stimulants, including methamphethamine
Registration Number
IRCT2014031611234N2
Lead Sponsor
Cognitive Sciences and Technology Council
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
180
Inclusion Criteria

Inclusion criteria are: (1) the methamphetamine dependents being referred for treatment to Vardij Therapeutic Community Residential Center which is a specialized center for stimulants; (2) a history of at least 12 months of meth dependence (moderate or severe) based on DSM-V criteria before receiving treatment; (3) Being in the age range of 18-50; (4) being abstinence from any drugs except cigarettes, for at least a week prior to the experiment, confirmed by urine analysis inside the residential centre; (5) A history of meth using at least 6 days a week in the month before entering the treatment. (6) Being able to provide informed, written consent. Exclusion criteria include: (1) any current major psychiatric disorders (2) Moderate to severe traumatic brain injury with evidence of neurological deficits, neurological disorders, or severe or unstable medical conditions that might be compromised by participation in the study; (3) having intracranial metal implantation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Immediate meth craving. Timepoint: Pre & Post brain stimulation. Method of measurement: visual-analogue scale(VAS).;Basic meth craving. Timepoint: Pre & Post brain stimulation. Method of measurement: Desires for Drug Questionnaire Adapted for Meth (DDQ).;Cue-induced craving. Timepoint: Pre & Post brain stimulation. Method of measurement: Computerized cue-induced craving assessment task (CICT).
Secondary Outcome Measures
NameTimeMethod
Mood state. Timepoint: Pre and Post brain stimulation. Method of measurement: Positive and Negative Affect (PANAS) questionnaire.
© Copyright 2025. All Rights Reserved by MedPath